AMPLIFY-7P: Phase 1 and randomized phase 2 study of amphiphile immunotherapy ELI-002 7P as adjuvant treatment for subjects with G12D, G12R, G12V, G12C, G12A, G12S and G13D Kirsten rat sarcoma (KRAS)-mutated pancreatic ductal adenocarcinoma (trial in progress)

Zev A. Wainberg, Vincent Chung, et al.
Presented at the ASCO Gastrointestinal Cancer Symposium
January 18-20, 2024